In this short video interview, Dr Marko Banovic (Clinical centre of Serbia, Belgrade, RS) discusses the AVATAR Trial. The trial evaluated aortic valve replacement (AVR) compared with conservative therapy among patients with asymptomatic severe aortic stenosis.
Presented first at AHA 2021, the trial showed that early AVR was beneficial at preventing adverse events among patients with asymptomatic severe aortic stenosis.
 
Discussion Points
1. Unmet Need in Asymptomatic AF and the Importance of AVATAR
2. Differences From RECOVERY and Definition of Asymptomatic AF
3. Design and Patient Population
4. Key Findings
5. Impact of COVID-19
6. Take-home Messages for Clinicians
7. Next Steps

Recorded remotely from Serbia, 2021. 

Interviewer: Mirjam Boros

Editor: Jordan Rance